UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | February 17, 2012 |
CONVERTED ORGANICS INC.
__________________________________________
(Exact name of registrant as specified in its charter)
Delaware | 001-33304 | 204075963 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
7A Commercial Wharf West, BOSTON, Massachusetts | 02110 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 617-624-0111 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders.
On February 17, 2012, the Company held a Special Meeting of Stockholders at its office in Boston, Massachusetts. At the Meeting, the Company's stockholders approved the following matters:
1. The authorization of the Board of Directors to amend the Certificate of Incorporation to implement a reverse split of the Company's issued and outstanding stock at a ratio of 1:500 (102,602,303 FOR, 46,099,983 AGAINST and 1,034,306 ABSTENTENTIONS); and
2. The authorization of the Board of Directors to abandon the reverse stock split at its discretion (138,836,604 FOR, 8,595,654 AGAINST and 2,304,334 ABSTENTIONS).
Item 9.01 Financial Statements and Exhibits.
Press Release dated February 17, 2012
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CONVERTED ORGANICS INC. | ||||
February 17, 2012 | By: |
Edward J. Gildea
|
||
|
||||
Name: Edward J. Gildea | ||||
Title: President & CEO |
Exhibit Index
Exhibit No. | Description | |
|
|
|
99.1
|
Press Release dated February 17, 2012 |